Peer-reviewed results from the two-level multi-center FDA Investigational Device Exemption study reiterate disc's superiority to ACDF The peer-reviewed publication reiterates that the Simplify Disc ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Net sales at NuVasive Inc increased 5.8% in the first ...
SAN DIEGO, Feb. 21, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally ...
SAN DIEGO, March 13, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally ...
Globus and NuVasive agreed to merge in a deal that will see Globus acquire its spinal surgery rival for 0.75 shares of GMED per NUVA share (or $3.1B). Globus shares sold off sharply, as the Street ...
Thank you. Good afternoon, everyone. With me today are Chris Barry, Chief Executive Officer; and Matt Harbaugh, Chief Financial Officer. Chris will provide an overview of NuVasive’s second quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results